Transcription of DATA SHEET 1. PNEUMOVAX - Medsafe
{{id}} {{{paragraph}}}
1 DATA SHEET 1. PNEUMOVAX 23 pneumococcal vaccine polyvalent, MSD, 25 microgram/ mL Single Dose Vial/Pre-filled Syringe 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each single dose vials/pre-filled syringe contains 25 mcg of each of the following pneumococcal polysaccharide serotypes: 1 2 3 4 5 6B** 7F 8 9N 9V** 10A 11A 12F 14** 15B 17F 18C 19A** 19F** 20 22F 23F** 33F. ** These serotypes most frequently cause medicine-resistant pneumococcal infections For the full list of excipients, see Section 3. PHARMACEUTICAL FORM Single dose vials/pre-filled syringes with a sterile clear colourless solution for intramuscular or subcutaneous administration. 4. CLINICAL PARTICULARS Therapeutic indications PNEUMOVAX 23 is indicated for vaccination against pneumococcal disease caused by those pneumococcal types included in the vaccine.
1 DATA SHEET 1. PNEUMOVAX® 23 Pneumococcal vaccine polyvalent, MSD, 25 microgram/serotype/0.5 mL Single Dose Vial/Pre-filled Syringe 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
PNEUMOVAX 23, As of 12/06/2011, Immunization, Immunization Schedule, Centers for Disease Control and Prevention, PCV13 vs PPSV23: Which to Give and, COMMON MEDICATIONS SAFE IN PREGNANCY, VACCINES FOR CHILDREN (VFC) PROGRAM, VACCINES FOR CHILDREN (VFC) PROGRAM VACCINE RECEIVING, For Adults without a Spleen